(Q50734200)

18 March 2018

title

Asymmetric dimethylarginine in homocystinuria due to cystathionine beta-synthase deficiency: relevance of renal function. (English)

1 reference

18 March 2018

1 reference

David E L Wilcken

1

1 reference

18 March 2018

Jun Wang

2

1 reference

18 March 2018

Ah Siew Sim

3

1 reference

18 March 2018

Kathryn Green

4

1 reference

18 March 2018

Bridget Wilcken

5

1 reference

18 March 2018

publication date

1 February 2006

1 reference

18 March 2018

Journal of Inherited Metabolic Disease

published in

1 reference

18 March 2018

volume

29

1 reference

18 March 2018

issue

1

1 reference

18 March 2018

page(s)

30-37

1 reference

18 March 2018

https://scigraph.springernature.com/pub.10.1007/s10545-006-0208-0

exact match

0 references

cites work

Covered stent septal ablation for hypertrophic obstruction cardiomyopathy.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10545-006-0208-0

The natural history of homocystinuria due to cystathionine beta-synthase deficiency.

21 January 2018

1 reference

12 December 2020

Cystatin C: an improved estimator of glomerular filtration rate?

1 reference

12 December 2020

Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate

1 reference

12 December 2020

Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study

1 reference

12 December 2020

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

1 reference

12 December 2020

Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.

1 reference

12 December 2020

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

1 reference

12 December 2020

Effects of homocysteine on the binding of extracellular-superoxide dismutase to the endothelial cell surface

1 reference

12 December 2020

Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.

1 reference

12 December 2020

Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypohomocysteinemia

1 reference

12 December 2020

Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction

1 reference

12 December 2020

Determination of asymmetric and symmetric dimethylarginines in plasma of hyperhomocysteinemic subjects

1 reference

12 December 2020

Vitamin C therapy ameliorates vascular endothelial dysfunction in treated patients with homocystinuria

1 reference

12 December 2020

Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes

1 reference

12 December 2020

Relationship between homocysteine and superoxide dismutase in homocystinuria: possible relevance to cardiovascular risk

1 reference

12 December 2020

Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans

1 reference

12 December 2020

The natural history of vascular disease in homocystinuria and the effects of treatment

1 reference

12 December 2020

Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease

1 reference

12 December 2020

Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis

1 reference

12 December 2020

The molecular basis of cystathionine beta-synthase deficiency in Australian patients: genotype-phenotype correlations and response to treatment

1 reference

12 December 2020

Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice.

1 reference

12 December 2020

Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA.

1 reference

12 December 2020

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase

1 reference

12 December 2020

Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents

1 reference

12 December 2020

Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement

1 reference

12 December 2020

Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease.

1 reference

12 December 2020

Inhibition of renal tubular reabsorption of homocystine by lysine and arginine

1 reference

12 December 2020

Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects

1 reference

12 December 2020

Established and emerging plasma biomarkers in the prediction of first atherothrombotic events

1 reference

12 December 2020

Homocyst(e)ine-lowering therapy does not affect plasma asymmetrical dimethylarginine concentrations in patients with peripheral artery disease

1 reference

12 December 2020

Cystatin C and the risk of death and cardiovascular events among elderly persons

1 reference

12 December 2020

Hyperhomocysteinaemia is not associated with increased levels of asymmetric dimethylarginine in patients with ischaemic heart disease

1 reference

12 December 2020

The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor

1 reference

12 December 2020

Elimination of asymmetric dimethylarginine by the kidney and the liver: a link to the development of multiple organ failure?

1 reference

12 December 2020

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

1 reference

12 December 2020

Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia

1 reference

12 December 2020

Asymmetric dimethylarginine and total homocysteine in plasma after oral methionine loading

1 reference

12 December 2020

Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans

1 reference

12 December 2020

Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography

1 reference

12 December 2020

The DDAH/ADMA/NOS pathway

1 reference

12 December 2020

10.1007/S10545-006-0208-0

Identifiers

DOI

1 reference

18 March 2018

1 reference

18 March 2018